Qingdao Haier Biomedical Co Ltd (688139) — Cash Flow Reinvestment Rate

Latest as of June 2023: 10.07x

Qingdao Haier Biomedical Co Ltd (688139) has a Cash Flow Reinvestment Rate of 10.07x as of June 2023, reinvesting CN¥73.78 Million (capex CN¥53.93 Million plus investments CN¥19.85 Million) from operating cash flow of CN¥7.33 Million. Explore Qingdao Haier Biomedical Co Ltd capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

10.07x
(Capex + Investments) / Operating CF

Total Reinvested

CN¥73.78 Million
Capex + Investments

Operating Cash Flow

CN¥7.33 Million
CNY

Capital Expenditures

CN¥53.93 Million
CNY

Qingdao Haier Biomedical Co Ltd Cash Flow Reinvestment Rate (2016–2025)

Historical reinvestment intensity for Qingdao Haier Biomedical Co Ltd across 10 annual periods. Also explore Qingdao Haier Biomedical Co Ltd total assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Qingdao Haier Biomedical Co Ltd (2016–2025)

Year-by-year capital reinvestment analysis for Qingdao Haier Biomedical Co Ltd. For live market cap and broader valuation context, see Qingdao Haier Biomedical Co Ltd (688139) total market value.

Year Reinvestment Rate Total Reinvested (CNY) Operating CF Capex YoY Change
2025 1.16x CN¥311.45 Million CN¥267.89 Million CN¥119.25 Million ▼ -46.3%
2024 2.17x CN¥631.63 Million CN¥291.67 Million CN¥126.70 Million ▲ +25.6%
2023 1.72x CN¥429.94 Million CN¥249.26 Million CN¥177.18 Million ▲ +202.8%
2022 0.57x CN¥360.26 Million CN¥632.43 Million CN¥294.24 Million ▼ -82.3%
2021 3.21x CN¥2.03 Billion CN¥632.43 Million CN¥204.69 Million ▲ +446.5%
2020 0.59x CN¥409.39 Million CN¥696.62 Million CN¥88.99 Million ▼ -75.3%
2019 2.38x CN¥668.07 Million CN¥280.49 Million CN¥168.40 Million ▼ -54.5%
2018 5.24x CN¥780.26 Million CN¥149.00 Million CN¥69.33 Million ▲ +468.1%
2017 0.92x CN¥136.72 Million CN¥148.32 Million CN¥26.98 Million ▼ -53.5%
2016 1.98x CN¥437.81 Million CN¥220.72 Million CN¥14.50 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow